Literature DB >> 15780733

Influenza vaccine in healthy children: a meta-analysis.

Eva Negri1, Carla Colombo, Laura Giordano, Nicola Groth, Giovanni Apolone, Carlo La Vecchia.   

Abstract

We conducted a meta-analysis of 13 randomised clinical trials evaluating the efficacy of influenza vaccine in healthy children. Against culture-confirmed influenza the overall efficacy was 74% (95% confidence interval, CI, 57%-84%), 65% for inactivated and 80% for live-attenuated vaccine. Corresponding figures were 59% (95% CI 43%-71%), 63% and 54% for serologically-confirmed influenza, and 33% (95% CI 29%-36%), 33% and 34% for clinical illness. Influenza vaccine is effective in preventing laboratory-confirmed and clinical influenza in healthy children, with no clear difference between inactivated and live-attenuated vaccine. Data on infants and younger children were too scanty to allow separate assessment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15780733     DOI: 10.1016/j.vaccine.2004.11.053

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  27 in total

Review 1.  Influenza vaccines: from surveillance through production to protection.

Authors:  Pritish K Tosh; Robert M Jacobson; Gregory A Poland
Journal:  Mayo Clin Proc       Date:  2010-01-29       Impact factor: 7.616

2.  Influenza vaccine after pediatric kidney transplant: a Midwest Pediatric Nephrology Consortium study.

Authors:  Corina Nailescu; Xiyan Xu; Hong Zhou; Henrietta Hall; Amy C Wilson; Jeffrey D Leiser; Deepa H Chand; Rudolph P Valentini; Diane Hebert; John D Mahan
Journal:  Pediatr Nephrol       Date:  2010-12-22       Impact factor: 3.714

3.  We will have to vaccinate healthy children against influenza when we know that it is helpful.

Authors:  Luis Moral; Eva María Rubio
Journal:  Eur J Pediatr       Date:  2006-05-25       Impact factor: 3.183

4.  [The universal influenza vaccination in children with Vaxigrip Tetra® in Italy: an evaluation of Health Technology Assessment].

Authors:  Sara Boccalini; Angela Bechini; Maddalena Innocenti; Gino Sartor; Federico Manzi; Paolo Bonanni; Donatella Panatto; Piero Luigi Lai; Francesca Zangrillo; Emanuela Rizzitelli; Mariasilvia Iovine; Daniela Amicizia; Chiara Bini; Andrea Marcellusi; Francesco Saverio Mennini; Alessandro Rinaldi; Francesca Trippi; Anna Maria Ferriero; Giovanni Checcucci Lisi
Journal:  J Prev Med Hyg       Date:  2018-05-30

5.  Economic benefits of inactivated influenza vaccines in the prevention of seasonal influenza in children.

Authors:  Luis Salleras; Encarna Navas; Nuria Torner; Andreu A Prat; Patricio Garrido; Núria Soldevila; Angela Domínguez
Journal:  Hum Vaccin Immunother       Date:  2013-01-07       Impact factor: 3.452

6.  Differences in antibody responses between trivalent inactivated influenza vaccine and live attenuated influenza vaccine correlate with the kinetics and magnitude of interferon signaling in children.

Authors:  Raquel G Cao; Nicolas M Suarez; Gerlinde Obermoser; Santiago M C Lopez; Emilio Flano; Sara E Mertz; Randy A Albrecht; Adolfo García-Sastre; Asuncion Mejias; Hui Xu; Huanying Qin; Derek Blankenship; Karolina Palucka; Virginia Pascual; Octavio Ramilo
Journal:  J Infect Dis       Date:  2014-02-04       Impact factor: 5.226

7.  Statement on Seasonal Influenza Vaccine for 2011-2012: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).

Authors: 
Journal:  Can Commun Dis Rep       Date:  2011-10-14

8.  Optimal pandemic influenza vaccine allocation strategies for the Canadian population.

Authors:  Ashleigh R Tuite; David N Fisman; Jeffrey C Kwong; Amy L Greer
Journal:  PLoS One       Date:  2010-05-06       Impact factor: 3.240

Review 9.  Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for influenza vaccination in children.

Authors:  Vytautas Usonis; Ioana Anca; Francis André; Roman Chlibek; Inga Ivaskeviciene; Atanas Mangarov; Zsófia Mészner; Roman Prymula; Pavol Simurka; Eda Tamm; Goran Tesović
Journal:  BMC Infect Dis       Date:  2010-06-14       Impact factor: 3.090

10.  Optimal pandemic influenza vaccine allocation strategies for the canadian population.

Authors:  Ashleigh Tuite; David N Fisman; Jeffrey C Kwong; Amy Greer
Journal:  PLoS Curr       Date:  2010-01-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.